PDF] Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial. Semantic Scholar CagriTirz (Cagrilintide + Tirz) >99% Purity Novo's Phase 3 CagriSema results disappoint analysts, sending stock tumbling MM+M Medical Marketing and Media Obesity phenotypes and atherogenic dyslipidemias Choe 2026 European Journal of Clinical Investigation Wiley Online Library The Rise of Next Generation Incretins: A New Era in Metabolic Medicine ESSI